Endometriosis News and Research

Latest Endometriosis News and Research

Soligenix reports results from orBec Phase 2 trial on acute GVHD

Soligenix, Inc., a development stage biopharmaceutical company, announced the publication of results from its investigator-initiated Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.

12 Dec 2011

Ovary removal in younger women may lead to low-bone mineral density, arthritis

Having both ovaries removed before age 45 is strongly associated with low-bone mineral density and arthritis in later years, according to a new study by Johns Hopkins oncologists and epidemiologists. The analysis covered several thousand women who took part in a U.S. government-sponsored, multiyear national health study, and excluded women whose ovaries were removed due to cancer.

9 Dec 2011

Soligenix third quarter revenues increase to $5,796,000

Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the third quarter of 2011.

14 Nov 2011

AHRQ: Only 8.7M of 12.1M women suffering from chronic pain received treatment in 2008

An estimated 12.1 million women age 18 and older reported suffering from chronic pain in 2008 as a result of underlying medical conditions such as chronic fatigue syndrome, endometriosis, fibromyalgia and vulvodynia. Of these women, only 8.7 million reported receiving treatment that year at a total cost of $12.9 billion, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

21 Oct 2011

AAGL to showcase innovative surgical approaches, teaching tools at 40th Global Congress

Technology has radically changed the way surgeons practice medicine, and nowhere is this more evident than in the field of gynecologic endoscopy. AAGL, the oldest professional organization devoted to teaching minimally invasive treatment for women's health problems, will showcase a number of innovative surgical approaches and teaching tools among the hundreds of postgraduate courses and practice labs offered at its annual Global Congress, November 6-11, 2011 at the Westin Diplomat in Hollywood, FL.

19 Oct 2011

Researchers identify mesothelin antibody that could detect early-stage ovarian cancer

Using a new approach to developing biomarkers for the very early detection of ovarian cancer, researchers at Rush University Medical Center have identified a molecule in the bloodstream of infertile women that could one day be used to screen for those at high risk for the disease — or even those with early-stage ovarian cancer.

17 Aug 2011

Soligenix second quarter revenues decrease to $406,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2011.

12 Aug 2011

Antioxidants may help treat infertility problems in both women and men

A growing body of evidence suggests that antioxidants may have significant value in addressing infertility issues in both women and men, including erectile dysfunction, and researchers say that large, specific clinical studies are merited to determine how much they could help.

29 Jul 2011

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Soligenix, Inc., a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc. for the development and commercialization of orBec into the European territory.

29 Jul 2011

Hope for fertility spreads through postcards

The campaign sends a multiplied message of hope for fertility in form of postcards with stories, including the key message on prevention and treatment. Thousands of postcards with moving stories are expected to cross Europe until October 2011.

4 Jul 2011

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

24 Jun 2011

Delayed treatment could prove effective in certain medical conditions

In today's fast-paced world, waiting — whether it's at the doctor's office, in line at the grocery store or for an Internet connection — is rarely considered a good thing.

3 Jun 2011

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Mitomics, world leader in the research and development of mitochondrial genome-based products, today announced it has entered into a non-exclusive licensing agreement with QDx Pathology Services to develop, market and process the QPredict™ Prostate Mitomic Test.

19 May 2011

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

As one of the first medical centers in the Northwest to perform robotic-assisted surgery, Swedish is home to the fastest growing, most comprehensive and experienced robotic-assisted surgical program in the region. Swedish established the multidisciplinary, robotic-assisted surgical program in 2005 and has since performed more than 3,400 robotic-assisted surgeries -- more than any other program in the region.

12 May 2011

Study finds link between high prenatal BPA levels and infant's neurobehavioral abnormalities

A new case study examining an infant's neurobehavioral abnormalities and extremely high bisphenol A concentration of the baby's mother suggests a link between the two.

12 May 2011

Porter Adventist Hospital introduces new institute for robotic surgery

Robotic surgery, once the stuff of science fiction, has for some years been recognized as an important advance in surgical technique and patient experience. Now, at Porter Adventist Hospital, a comprehensive team of surgeons and staff are helping to bring in a new era in robotic surgery.

2 May 2011

The AFA completes yearlong fertility educational series

The American Fertility Association is pleased to announce the completion of a yearlong fertility educational series which was funded by Attain Fertility Centers.

30 Apr 2011

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Neurocrine Biosciences, Inc. announced today that it has completed the dosing and preliminary assessment of the initial cohort of Tardive Dyskinesia patients using its proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

6 Apr 2011

Mitomics introduces new test to detect prostate cancer

Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.

1 Apr 2011

ETH scientists warn about impact of cell phone radiation in brain of healthy adults

Expert scientists working with Environmental Health Trust, a nonprofit research and educational group, say that new studies showing that cell phone radiation excites the brain strengthen the need for a major research program on cell phones and health, revamping approaches to setting standards, and putting warnings on cell phones.

23 Feb 2011

Endometriosis News and Research

Latest Endometriosis News and Research

Soligenix reports results from orBec Phase 2 trial on acute GVHD

Ovary removal in younger women may lead to low-bone mineral density, arthritis

Soligenix third quarter revenues increase to $5,796,000

AHRQ: Only 8.7M of 12.1M women suffering from chronic pain received treatment in 2008

AAGL to showcase innovative surgical approaches, teaching tools at 40th Global Congress

Researchers identify mesothelin antibody that could detect early-stage ovarian cancer

Soligenix second quarter revenues decrease to $406,000

Antioxidants may help treat infertility problems in both women and men

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Hope for fertility spreads through postcards

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Delayed treatment could prove effective in certain medical conditions

Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate Mitomic Test

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

Study finds link between high prenatal BPA levels and infant's neurobehavioral abnormalities

Porter Adventist Hospital introduces new institute for robotic surgery

The AFA completes yearlong fertility educational series

Neurocrine completes NBI-98854 Phase IIa study in schizophrenia patients with dyskinesia

Mitomics introduces new test to detect prostate cancer

ETH scientists warn about impact of cell phone radiation in brain of healthy adults

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Endometriosis News and Research

Latest Endometriosis News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in